The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection
The efficacy and safety of CAR-T cell therapy in patients with refractory ALL and concomitant HBV infection
复制标题
DOI：
10.1038/s41375-020-0952-4
复制
发表时间：
2020
期刊：
影响因子：
--
通讯作者：
Xin
中科院分区：
文献类型：
--
作者：
Peilong Lai;Xiaomei Chen;Le Qin;Zhiwu Jiang;Chenwei Luo;Xin Huang;Sujing Wu;Wei Ling;Yulian Wang;Jinghua Wang;Chenxin Deng;Lisi Huang;Lingji Zeng;Zesheng Lu;Liye Zhong;Pengjun Liao;Minming Li;Dongmei Chen2;Suxia Geng;Ping Wu;Zhaoyang Tang;Duanqing Pei;Xin
